More PRNewswire
View Older Stories View Newer Stories-
YS Biopharma Announces Results of Extraordinary General Meeting held on February 22, 2024
-
Broadridge to Participate in Upcoming Investor Events
-
BOARDWALKTECH TO ANNOUNCE FISCAL Q3 2024 FINANCIAL RESULTS ON FEBRUARY 28, 2024
-
Instant Brands Restructuring Plan Confirmed by Court
-
Explaining Primary Progressive Aphasia: Neurological Condition Affecting Wendy Williams and Bruce Willis Is Often Misdiagnosed, Misunderstood
-
Cotopaxi Introduces Más Vida Resale Program
-
Two thirds of PR Pros can't prove their work helps their business or client: CoverageBook
-
Albemarle Announces Quarterly Dividend
-
Lotus Tech and L Catterton Asia Acquisition Corp Complete Business Combination
-
MSA Safety Elects Steve Blanco CEO as Part of Planned Management Succession; Nish Vartanian to Retire
-
Fannie Mae Appoints Peter Akwaboah as Chief Operating Officer
-
Travelzoo Q4 2023 Earnings Conference Call on February 28 at 11:00 AM ET
-
Royal Caribbean Group announces upsizing and pricing of $1.25 billion offering of senior unsecured notes to refinance its senior notes due 2027
-
MSA Safety Announces the Retirement of John T. Ryan III, Director
-
Secureworks to Report Fourth Quarter and Full Year Fiscal 2024 Financial Results on March 14, 2024
-
NOBLE CORPORATION PLC ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 RESULTS
-
Ameren Announces 2023 Results and Issues Guidance for 2024 Earnings and Long-Term Growth
-
Select Medical Holdings Corporation Announces Results For Its Fourth Quarter and Year Ended December 31, 2023 and Cash Dividend
-
Kroger Announces Fourth Quarter Conference Call with Investors
-
ZK International Receives Nasdaq Notices Regarding Listing Deficiency
-
Paramount Global Declares Quarterly Cash Dividends
-
REcore Acquiring NorthstarMLS Proprietary Technology
-
Allspring Closed-End Funds Declare Monthly and Quarterly Distributions; Allspring Announces Change to Investment Strategy Guidelines for two Closed-End Funds
-
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Cohen & Steers, Inc. Declares Quarterly Dividend
-
NASA Awards Spaceflight Development, Operations Contract
-
Arcadium Lithium Releases Fourth Quarter and Full Year 2023 Results and Provides 2024 Full Year Outlook
-
AMH Announces CEO Succession Plan
-
ALAMO GROUP INC. ANNOUNCES RETIREMENT OF BOARD MEMBER, APPOINTMENT OF NEW BOARD CHAIR AND APPOINTMENT OF NEW DIRECTOR
-
Extra Space Storage Inc. Announces 1st Quarter 2024 Dividend
-
Celsius Holdings, Inc. to Release Fourth Quarter and Full Year 2023 Results on Thursday, Feb. 29, 2024
-
Invesco Mortgage Capital Inc. Reports Fourth Quarter 2023 Financial Results
-
ALAMO GROUP ANNOUNCES RECORD 2023 FOURTH QUARTER AND YEAR END RESULTS
-
Lumen strengthens technology transformation with new board appointment
-
Environmental Solutions Group Announces Further Expansion of Innovative Solid Waste & Recycling Technology Solutions
-
Danaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction Targets
-
RE/MAX HOLDINGS, INC. PROMOTES AMY LESSINGER TO PRESIDENT OF RE/MAX, LLC, ABBY LEE TO EVP OF MARKETING, COMMUNICATIONS, AND EVENTS, AND SUSIE WINDERS TO EVP, GENERAL COUNSEL
-
MAIN STREET ANNOUNCES 2023 FOURTH QUARTER AND ANNUAL RESULTS
-
Invesco Mortgage Capital Inc. Announces 2024 Annual Stockholders Meeting
-
EOG Resources Reports Fourth Quarter and Full-Year 2023 Results; Announces 2024 Capital Plan
-
Cognizant Expands Technology Operations Partnership with CNO Financial Group
-
RE/MAX HOLDINGS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2023 RESULTS
-
CROWN HOLDINGS, INC. DECLARES QUARTERLY DIVIDEND
-
Evolent Announces Fourth Quarter and Full Year 2023 Results
-
Vapotherm Reports Fourth Quarter and Fiscal Year 2023 Financial Results
-
AMH Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
-
Squarespace to Participate at the Morgan Stanley Technology, Media & Telecom Conference
-
Live Nation Entertainment Reports Full Year And Fourth Quarter 2023 Results
-
DIAMONDROCK HOSPITALITY COMPANY REPORTS FOURTH QUARTER AND FULL YEAR 2023 RESULTS
-
Renibus Therapeutics to Present at the Evercore ISI 2024 Emerging Biotech Conference

